UZH-Logo

Maintenance Infos

Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates


Schott, H; Schwendener, R (1996). Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates. Anti-Cancer Drug Design, 11(6):451-62.

Abstract

N4-Hexadecyl-1-beta-D-arabinofuranosylcytosine (hxd4araC), a new cytostatic derivative of the antileukemic drug 1-beta-D-arabinofuranosylcytosine (araC), was linked in gram-scale syntheses to phospholipids containing differently substituted glycerol residues. All phospholipid-araC conjugates which were condensed via a phosphotriester linkage were shown to be ineffective in the in vivo treatment of L1210 murine leukemia. The transformation of the triesters into phosphodiester-linked conjugates by cleavage of the 2-chlorophenyl protecting group resulted in conjugates which were highly active against L1210 leukemia. These conjugates form stable liposomes with matrix lipids which exert antileukemic effects depending on the number and characteristics of the lipophilic residues of the conjugates. By treatment of L1210 leukemic mice with 100 mumol/kg body wt as total dose given by i.p. injection on days 2 and 6 after tumor inoculation with liposomal hxd4araC or 1-O-octadecyl-rac-glycero-3-phosphoryl-(3-->5')-1- beta-D-arabino-furanosylcytosine (Ocd1GroP-araC) the fraction of 60-day survivors was 100%. Corresponding curative effects were observed after treatment with 200 mumol/kg of 1,2-O-dipalmitoyl-rac-glycero-3-phosphoryl-(3-->5')-N4-palmitoyl-1-beta- D-arabinofuranosylcytosine (Pam1pam2GroP-pam4araC); 1,2-O-dioctadecyl-rac-glycero-3-phosphoryl- (3-->5')-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (Ocd1ocd2GroP-pam4araC) or 1-O-octadecyl-rac-glycero-3-phosphoryl-(3-->5')-hxd4araC (Ocd1GroP-hxd4araC). Four other conjugates with differently combined palmitoyl-, octadecyl- and hexadecyl residues were significantly less active or inactive. A distinct relationship between the chemical structures and the antileukemic activity of the nine investigated compounds was not found.

Abstract

N4-Hexadecyl-1-beta-D-arabinofuranosylcytosine (hxd4araC), a new cytostatic derivative of the antileukemic drug 1-beta-D-arabinofuranosylcytosine (araC), was linked in gram-scale syntheses to phospholipids containing differently substituted glycerol residues. All phospholipid-araC conjugates which were condensed via a phosphotriester linkage were shown to be ineffective in the in vivo treatment of L1210 murine leukemia. The transformation of the triesters into phosphodiester-linked conjugates by cleavage of the 2-chlorophenyl protecting group resulted in conjugates which were highly active against L1210 leukemia. These conjugates form stable liposomes with matrix lipids which exert antileukemic effects depending on the number and characteristics of the lipophilic residues of the conjugates. By treatment of L1210 leukemic mice with 100 mumol/kg body wt as total dose given by i.p. injection on days 2 and 6 after tumor inoculation with liposomal hxd4araC or 1-O-octadecyl-rac-glycero-3-phosphoryl-(3-->5')-1- beta-D-arabino-furanosylcytosine (Ocd1GroP-araC) the fraction of 60-day survivors was 100%. Corresponding curative effects were observed after treatment with 200 mumol/kg of 1,2-O-dipalmitoyl-rac-glycero-3-phosphoryl-(3-->5')-N4-palmitoyl-1-beta- D-arabinofuranosylcytosine (Pam1pam2GroP-pam4araC); 1,2-O-dioctadecyl-rac-glycero-3-phosphoryl- (3-->5')-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (Ocd1ocd2GroP-pam4araC) or 1-O-octadecyl-rac-glycero-3-phosphoryl-(3-->5')-hxd4araC (Ocd1GroP-hxd4araC). Four other conjugates with differently combined palmitoyl-, octadecyl- and hexadecyl residues were significantly less active or inactive. A distinct relationship between the chemical structures and the antileukemic activity of the nine investigated compounds was not found.

Citations

7 citations in Web of Science®
7 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Molecular Cancer Research
07 Faculty of Science > Institute of Molecular Cancer Research
Dewey Decimal Classification:570 Life sciences; biology
Language:English
Date:1996
Deposited On:20 Oct 2009 14:24
Last Modified:05 Apr 2016 13:30
Publisher:Oxford University Press
ISSN:0266-9536
PubMed ID:8836110

Download

Full text not available from this repository.

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations